Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.

NCT04309981 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

BIOLOGICAL: Adult differentiated autologous T-cells with anti-BCMA specificity

Sponsor

Sara V. Latorre

Collaborators

[object Object]
[object Object]
[object Object]